Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

NCT04822883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Cognitive Impairment
Schizophrenia

Interventions

DRUG: RL-007
DRUG: RL-007 Matching Placebo

Sponsor

Recognify Life Sciences